Beta Bionics (BBNX) Equity Average (2024 - 2026)

Beta Bionics' Equity Average history runs 3 years deep, the most recent figure standing at $279.4 million for Q1 2026.

• In Q1 2026, Equity Average rose 717.14% year-over-year to $279.4 million; the TTM figure through Mar 2026 stood at $279.4 million (up 717.14% YoY), while the FY2025 annual figure was $21.1 million, up 109.42% from the prior year.
• Equity Average came in at $279.4 million for Q1 2026 at Beta Bionics, down from $291.2 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $307.7 million in Q2 2025 to a low of -$237.1 million in Q4 2024.
• A 3-year average of $35.8 million and a median of $34.2 million in 2025 frame the typical range for Equity Average.
• Across the five-year window, Equity Average surged 116.38% in 2025 and jumped 717.14% in 2026, its largest moves.
• Beta Bionics' Equity Average stood at -$237.1 million in 2024, then jumped by 222.81% to $291.2 million in 2025, then slipped by 4.04% to $279.4 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $279.4 million, $291.2 million, and $298.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison